Infants vertically infected with human immunodeficiency virus type 1 (
HIV-1) often manifest profoundly deficient growth with failure to thri
ve. The pathologic mechanisms that produce growth failure associated w
ith pediatric HIV infection are not clear. Transgenic mice homozygous
for a gag/pol deletion mu tant of the infectious provirus pNL4-3 have
been found to manifest a similar growth failure pattern. To explore th
e influence of HIV-1 on fetal growth and maternal-fetal interactions,
we examined intrauterine growth of transgenic and nontransgenic mice a
nd evaluated the consequence of embryo transfer into normal and hetero
zygous transgenic mothers. Mice homozygous for the HIV transgene had n
ormal intrauterine and birth weights but uniformly displayed severe gr
owth retardation postnatally. Transgene expression was prominent in tr
ansgenic fetuses and their placentas and in uteri of transgenic mother
s, as determined by Northern analysis. Although embryo transfer did no
t affect intrauterine growth, the pregnancy rate in transgenic mothers
was markedly lower than in nontransgenic controls. In both fetal and
neonatal tissues, transgene expression was significantly greater in ho
mozygous animals when compared with heterozygotes, but the difference
was magnified postnatally. These results suggest that HIV gene express
ion affected both mother and neonate. In the mother, expression of the
HIV-1 transgene reduced postfertilization pregnancy rate, Once the an
imal was pregnant, however, the effects of transgene expression on the
homozygous fetus were overcome in utero, possibly by the contribution
of maternal factors or by inhibition of HIV-1 gene expression by a fe
tal or maternal factor(s). In the neonate, HIV-1 transgene expression
increased dramatically in homozygotes and was associated with profound
growth failure. Thus, the expression of HIV-1 and its consequences ar
e complex and dependent on important maternal-fetal interactions.